Literature DB >> 16607381

Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma.

Jun Nishio1, Pamela A Althof, Jacqueline M Bailey, Ming Zhou, James R Neff, Frederic G Barr, David M Parham, Lisa Teot, Stephen J Qualman, Julia A Bridge.   

Abstract

A valuable diagnostic adjunct and important prognostic parameter in alveolar rhabdomyosarcoma (ARMS) is the identification of translocations t(2;13)(q35;q14) and t(1;13)(p36;q14), and the associated PAX3-FKHR and PAX7-FKHR fusion transcripts, respectively. Most RMS fusion gene type studies have been based on reverse transcriptase-polymerase chain reaction (RT-PCR) detection of the fusion transcript, a technique limited by RNA quality and failure of devised primer sets to detect unusual variants. As an alternative approach, we developed a fluorescence in situ hybridization (FISH) assay that can: (1) distinguish between the two most common ARMS-associated fusion genes; (2) identify potential unusual variant translocations; (3) assess histologic components in mixed alveolar/embryonal RMS; and (4) be performed on paraffinized tissue. FISH analyses of 75 specimens (40 ARMS, 16 ERMS, 8 mixed ARMS/ERMS, and 11 non-RMS tumors) using selected cosmid clone, bacterial, P1-derived, and yeast artificial chromosome probe sets were successful in all but two cases. Among specimens with informative results for both FISH and RT-PCR or standard karyotyping, PAX/FKHR classification results were concordant in 94.6% (53/56). The three discordant cases included one exhibiting a t(2;13) by FISH that was subsequently confirmed by repeat RT-PCR, a second showing a rearrangement of the PAX3 locus only (consistent with the presence of a PAX3 variant translocation), and a third revealing a t(2;13) by FISH that lacked this translocation cytogenetically. Both alveolar and embryonal components of the mixed ARMS/ERMS subtype were negative for PAX3, PAX7, and FKHR rearrangements, a surprising finding confirmed by RT-PCR and/or conventional karyotyping. These data demonstrate that FISH with newly designed probe sets is a reliable and highly specific method of detecting t(1;13) and t(2;13) in routinely processed tissue and may be useful in differentiating ARMS from other small round cell tumors. The findings also suggest that FISH may be a more sensitive assay than RT-PCR in some settings, capable of revealing variant translocations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16607381     DOI: 10.1038/labinvest.3700416

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

1.  Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Authors:  Kayo Suzuki; Taketoshi Yasuda; Kenta Watanabe; Takeshi Hori; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

2.  Clinical utility gene card for: Alveolar rhabdomyosarcoma.

Authors:  Zhongxin Yu; Anna Kelsey; Rita Alaggio; David Parham
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

3.  Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.

Authors:  Michael A Arnold; James R Anderson; Julie M Gastier-Foster; Frederic G Barr; Stephen X Skapek; Douglas S Hawkins; R Beverly Raney; David M Parham; Lisa A Teot; Erin R Rudzinski; David O Walterhouse
Journal:  Pediatr Blood Cancer       Date:  2016-01-12       Impact factor: 3.167

4.  Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.

Authors:  Erin R Rudzinski; James R Anderson; Elizabeth R Lyden; Julia A Bridge; Frederic G Barr; Julie M Gastier-Foster; Karen Bachmeyer; Stephen X Skapek; Douglas S Hawkins; Lisa A Teot; David M Parham
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

5.  Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?

Authors:  Tobias M Dantonello; Christian Vokuhl; Monika Scheer; Monika Sparber-Sauer; Sabine Stegmaier; Guido Seitz; Heike Scheithauer; Jörg Faber; Iris Veit-Friedrich; Peter Kaatsch; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Journal:  Virchows Arch       Date:  2018-02-21       Impact factor: 4.064

6.  Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Erin R Rudzinski; James R Anderson; Yueh-Yun Chi; Julie M Gastier-Foster; Caroline Astbury; Frederic G Barr; Stephen X Skapek; Douglas S Hawkins; Brenda J Weigel; Alberto Pappo; William H Meyer; Michael A Arnold; Lisa A Teot; David M Parham
Journal:  Pediatr Blood Cancer       Date:  2017-05-18       Impact factor: 3.167

7.  The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma.

Authors:  Khin Thway; Jayson Wang; Dorte Wren; Melissa Dainton; David Gonzalez; John Swansbury; Cyril Fisher
Journal:  Virchows Arch       Date:  2015-04-26       Impact factor: 4.064

8.  Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.

Authors:  Janos Sumegi; Renae Streblow; Robert W Frayer; Paola Dal Cin; Andrew Rosenberg; Aurelia Meloni-Ehrig; Julia A Bridge
Journal:  Genes Chromosomes Cancer       Date:  2010-03       Impact factor: 5.006

9.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

10.  Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas.

Authors:  Tadaki Matsumura; Takehiko Yamaguchi; Kunihiko Seki; Tadakazu Shimoda; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.